ZFP36 and B-cell non-Hodgkin lymphoma: This finding is consistent with the observation that aged mice decrease ZFP36 compared with their younger counterparts.53 Moreover, the well-known protooncogene c-Myc transcriptionally represses ZFP36 and is selected for in various malignancies including, but not limited to, B cell lymphomas.54 We raise the possibility of ZFP36 as a pharmacologic target for stabilization to exploit its pleiotropic affects and inherent biological specificity in various cell growth processes.